These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15006720)

  • 21. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
    Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
    Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular approaches to the identification of biomarkers of exposure and effect--report of an expert meeting organized by COST Action B15. November 28, 2003.
    Gundert-Remy U; Dahl SG; Boobis A; Kremers P; Kopp-Schneider A; Oberemm A; Renwick A; Pelkonen O
    Toxicol Lett; 2005 Apr; 156(2):227-40. PubMed ID: 15737486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of DNA tiling arrays to experimental genome annotation and regulatory pathway discovery.
    Bertone P; Gerstein M; Snyder M
    Chromosome Res; 2005; 13(3):259-74. PubMed ID: 15868420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker discovery using molecular profiling approaches.
    Walker SJ; Xu A
    Int Rev Neurobiol; 2004; 61():1-30. PubMed ID: 15482809
    [No Abstract]   [Full Text] [Related]  

  • 25. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial neural network technologies to identify biomarkers for therapeutic intervention.
    Bicciato S
    Curr Opin Mol Ther; 2004 Dec; 6(6):616-23. PubMed ID: 15663326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated expressional analysis: application to the drug discovery process.
    Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
    Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Data analysis of alternative splicing microarrays.
    Cuperlovic-Culf M; Belacel N; Culf AS; Ouellette RJ
    Drug Discov Today; 2006 Nov; 11(21-22):983-90. PubMed ID: 17055407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of molecular, cellular, and genetic neurotoxicology.
    Wallace DR
    Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging applications of kinetic biomarkers in preclinical and clinical drug development.
    Turner SM; Hellerstein MK
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):115-26. PubMed ID: 15679179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In pursuit of effective toxicogenomics.
    Gant TW; Zhang SD
    Mutat Res; 2005 Aug; 575(1-2):4-16. PubMed ID: 15885710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarrays: interrogating the transplant transcriptosome.
    Shah S; Sarwal MM
    Clin Transpl; 2004; ():261-7. PubMed ID: 16704157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational biology for cardiovascular biomarker discovery.
    Azuaje F; Devaux Y; Wagner D
    Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
    Ross JS; Ginsburg GS
    Expert Rev Mol Diagn; 2002 Nov; 2(6):531-41. PubMed ID: 12465450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.